Curcumin, from turmeric, inhibits NF-κB and STAT3 signaling, attenuating tumor progression and enhancing anticancer immunity by stabilizing PD-L1 and reducing CSN5 activity, a deubiquitinase modulating PD-L1 ubiquitination [145, 146]. The gene discussed is COPS5; the disease is neoplasm.